发布时间:
2021
-
08
-
02
点击次数:
0
所属职位：
COO, Biosion, Inc. & President, Biosion USA, Inc.
所属公司：
Biosion, Inc.
个人简介：
Dr. Davis is currently the Chief Operating Officer of Biosion, Inc. & President, Biosion, USA, Inc. Dr. Davis brings to Biosion over 30 years of global Research & Development experience in the biotech and pharmaceutical industries. Dr. Davis joined Biosion from Frontage Laboratories, Inc., where he served as Chief Business Officer, leading the company to a very successful IPO in May of 2019. Prior to Frontage, Dr. Davis worked with Johnson & Johnson where he served as Vice President and Head of Biologics Development Sciences and China Biologics Leader in the Janssen Biotherapeutics division of Janssen R&D, LLC since 2001. During his tenure in J&J, Hugh and his team were instrumental in the development and approval of many biologic therapies including Remicade, Stelara, Simponi, Sylvant, Darzalex and Tremfya. Prior to J&J, Hugh led the Pharmacodynamics & Exploratory Research Laboratory in the Clinical Pharmacology Unit at Glaxo SmithKline from 1996 to 2001. Dr. Davis holds a Ph.D. degree in Biochemistry from Villanova University and completed his Post-Doctoral training at Centocor, Inc.